Crinetics Pharmaceuticals Inc.

This study tested an experimental drug called CRN04894 in adults with congenital adrenal hyperplasia (CAH), a rare genetic condition that affects hormone production. Thirty-eight participants took the drug for 12 weeks while continuing their standard steroid medications. Research…

This study tested a new oral drug called paltusotine for people with carcinoid syndrome, which causes flushing and diarrhea from certain neuroendocrine tumors. Thirty-six participants took different doses for 8 weeks, with the option to continue for up to 28 months total. The mai…

This completed early-stage study aimed to understand how the body processes a new drug called atumelnant and to check its safety in healthy people. It involved 21 healthy Japanese and Caucasian adults who received either the drug or a placebo. The main goals were to measure drug …